Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.39 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.38 |
| ▸ | F10 | P00742 | 1/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.36 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.34 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | TGFBR1 | P36897 | 2/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | QPCT | Q16769 | 1/20 | 0.34 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.34 |
| ▸ | ABL1 | P00519 | 1/20 | 0.34 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
| ▸ | HCK | P08631 | 1/20 | 0.34 |
| ▸ | SRC | P12931 | 1/20 | 0.34 |
| ▸ | KDR | P35968 | 1/20 | 0.34 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21364619 | 0.79 | PIK3C3 (0.46) | PIK3C3DYRK1ATGFBR1QPCTPIK3CD | |
| SCHEMBL174229 | 0.74 | DYRK1A (0.43) | PIK3C3DYRK1AKEAP1KMT2AMEN1 | |
| SCHEMBL11026 | 0.74 | L3MBTL1 (0.40) | PIK3C3DYRK1AKEAP1KMT2AMEN1 | |
| SCHEMBL17868755 | 0.74 | PIK3C3 (0.38) | PIK3C3DYRK1AKEAP1KMT2AMEN1 | |
| SCHEMBL601353 | 0.74 | PIK3C3 (0.41) | PIK3C3DYRK1AKEAP1KMT2AMEN1 | |
| SCHEMBL3185174 | 0.74 | PIK3C3 (0.38) | PIK3C3DYRK1AKEAP1KMT2AMEN1 | |
| SCHEMBL14144231 | 0.74 | PIK3C3 (0.38) | PIK3C3DYRK1AKEAP1KMT2AMEN1 | |
| SCHEMBL20755769 | 0.74 | PIK3C3 (0.38) | PIK3C3DYRK1AKEAP1KMT2AMEN1 | |
| SCHEMBL18554370 | 0.74 | OGA (0.39) | PIK3C3DYRK1AKEAP1KMT2AMEN1 | |
| SCHEMBL557143 | 0.74 | SMN1; SMN2 (0.44) | PIK3C3KEAP1KMT2ACYP1A2TGFBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119350428-B | Respiratory system medicine synergist based on pyruvate and preparation method and application thereof | 江苏长泰药业股份有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-119350428-A | Respiratory system medicine synergist based on pyruvate and preparation method and application thereof | 江苏长泰药业股份有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-112409354-B | Synthesis process of 7-fluoroimidazo [1,2-A ] pyridine and intermediate thereof | 苏利制药科技江阴有限公司 | 2021-10-08 | — | — | CN | claimed |
| CN-112409354-A | Synthesis process of 7-fluoroimidazo [1,2-A ] pyridine and intermediate thereof | 苏利制药科技江阴有限公司 | 2021-02-26 | — | — | CN | claimed |
| EP-3340982-A1 | COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS | Achillion Pharmaceuticals, Inc. (US) | 2018-07-04 | — | — | EP | claimed |
| WO-2017035408-A1 | COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS | ACHILLION PHARMACEUTICALS, INC. (US) | 2017-03-02 | — | — | WO | claimed |
| EP-4688777-A1 | NOVEL PD-L1 INHIBITORS | Affirma Biotech S. L. (ES) | 2026-02-11 | — | — | EP | disclosed |
| US-12391679-B2 | Benzamide-substituted bicyclic imidazo- and pyrazolo-fused -pyridine, -pyrimide, and -pyridazine compounds for treatment of inflammatory diseases | ONCO3R THERAPEUTICS BV (BE) | 2025-08-19 | — | — | US | disclosed |
| US-12338230-B2 | Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders | ACHILLION PHARMACEUTICALS, INC. (US) | 2025-06-24 | — | — | US | disclosed |
| CN-119350428-B | Respiratory system medicine synergist based on pyruvate and preparation method and application thereof | 江苏长泰药业股份有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-119350428-B | Respiratory system medicine synergist based on pyruvate and preparation method and application thereof | 江苏长泰药业股份有限公司 | 2025-03-28 | — | — | CN | disclosed |
| WO-2025038525-A1 | FMS-LIKE TYROSINE KINASE 3 (FLT3) INHIBITORS FOR TREATING CELL PROLIFERATIVE DISEASES OR CONDITIONS | BIOVENTURES, LLC (US) | 2025-02-20 | — | — | WO | disclosed |
| CN-119350428-A | Respiratory system medicine synergist based on pyruvate and preparation method and application thereof | 江苏长泰药业股份有限公司 | 2025-01-24 | — | — | CN | disclosed |
| WO-2001038326-A2 | IMIDAZO-PYRIDINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS | MERCK SHARP & DOHME LIMITED (GB) | 2001-05-31 | — | — | WO | disclosed |
| US-4163745-A | ANTIDIABETIC, HYPOGLYCEMIC | PFIZER INC. (US) | 1979-08-07 | — | — | US | disclosed |
| US-4141898-A | Imidazo pyridinium quaternary salts as hypoglycemic agents | PFIZER INC. (US) | 1979-02-27 | — | — | US | disclosed |
| US-4129567-A | IMIDAZOPYRIDINES AND ISOB IDINE | PFIZER INC. (US) | 1978-12-12 | — | — | US | disclosed |
| US-4097598-A | Quaternary salts as hypoglycemic agents | PFIZER INC. (US) | 1978-06-27 | — | — | US | disclosed |
| US-4093616-A | PYRROLO(1,2-A)PYRAZINIUM, PYRAZOLO(1,5-A)PYRIDINIUM, 1H-IMIDAZO(2,1-A)ISOQUINOLINIUM, OR IMIDAZO(5,1-A)ISOQUINOLINIUM SALTS | PFIZER INC. (US) | 1978-06-06 | — | — | US | disclosed |
| US-4044015-A | Imidazopyridinium compounds as hypoglycemic agents | PFIZER INC. (US) | 1977-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12338230-B2 | Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders | CFD, TFPI, CFH | EGLN2 995/4885PIK3C3 225/4885F10 50/4885 |
| US-12391679-B2 | Benzamide-substituted bicyclic imidazo- and pyrazolo-fused -pyridine, -pyrimide, and -pyridazine compounds for treatment of inflammatory diseases | IL5, IL15, IL1A | EGLN2 1189/4885PIK3C3 419/4885F10 222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.